ERBB2 and cancer: It should also be noticed that the distant disease-free survival of nonparticipant HER2 + and TN cancers was worse than that of PSBCs (age-adjusted HR = 2.52, 95% CI 0.63–10.11 and HR = 5.30, 95% 1.16–24.29, respectively).